|Erlotinib as salvage treatment after failure to first-line Gefitinib in non-small cell lung cancer|
Cancer Chemotherapy and Pharmacology
Springer. The Journal's web site is located at http://www.springer.com/medicine/oncology/journal/280
|Wong, MK; Lo, AI; Lam, B; Lam, WK; Ip, MS; Ho, JC||2010||837|
|Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer|
Journal of Thoracic Oncology
Lippincott Williams & Wilkins.
|Wong, MKY; Lo, AI; Lam, WK; Lam, B; Ip, MSM; Ho, JCM||2009||258|